
Alvotech (ALVO) shares have risen 10.1% in the past four weeks, and analysts' price targets suggest a potential 72.6% upside, with a mean target of $18.40. While the article cautions against relying solely on analyst price targets due to potential biases, it notes a strong correlation between positive earnings estimate revisions and near-term stock price movements, with the Zacks Consensus Estimate for the current year increasing 251.4% over the last 30 days.
Alvotech (ALVO) shares have demonstrated positive momentum, gaining 10.1% over the past four weeks to close at $10.66. Wall Street analysts project further significant upside, with a mean price target of $18.40, implying a 72.6% potential increase from the current level. This average is derived from five estimates ranging from $14 to $28, with a standard deviation of $5.73, indicating some dispersion in analyst outlooks. While the article advises caution regarding the general reliability of analyst price targets due to potential biases, it emphasizes that the bullish outlook for ALVO is substantiated by more compelling evidence: a significant positive trend in earnings estimate revisions. Specifically, the Zacks Consensus Estimate for Alvotech's current year earnings per share has surged by an impressive 251.4% over the last 30 days, driven by two upward revisions and no counteracting negative revisions. This strong agreement among analysts on improving earnings prospects, coupled with ALVO's Zacks Rank #1 (Strong Buy), is presented as a robust indicator, as empirical research suggests a strong correlation between such revisions and near-term stock price movements.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.60
Ticker Sentiment